Yueh Hsin Lai

Director/Miembro de la Junta en CytoPharm, Inc. .

Health Technology

Perfil

Yueh Hsin Lai is currently a Director-Supervisory Board at CytoPharm, Inc. and a Director at Tai Hsin Venture Capital Co., Ltd., Fu Yung Biotechnology Co. Ltd., and Fu Yung Investment Co. Ltd.
Previously, Lai was a Director at EPS Bio Technology Corp.

Cargos activos de Yueh Hsin Lai

Empresas	Cargo	Inicio
CytoPharm, Inc. CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan.	Director/Miembro de la Junta	22/09/2011
Fu Yung Biotechnology Co. Ltd.	Director/Miembro de la Junta	22/09/2011
Fu Yung Investment Co. Ltd.	Director/Miembro de la Junta	22/09/2011
Tai Hsin Venture Capital Co., Ltd. /Taiwan/	Director/Miembro de la Junta	-

Todos los cargos activos de Yueh Hsin Lai

Antiguos cargos conocidos de Yueh Hsin Lai.

Empresas	Cargo	Fin
EPS BIO TECHNOLOGY CORP.	Director/Miembro de la Junta	-

Ver el detalle de la experiencia de Yueh Hsin Lai.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yueh Hsin Lai.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
EPS BIO TECHNOLOGY CORP.	Health Technology

Empresas privadas	4
CytoPharm, Inc. CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan.	Health Technology
Fu Yung Biotechnology Co. Ltd.
Fu Yung Investment Co. Ltd.
Tai Hsin Venture Capital Co., Ltd. /Taiwan/

Ver las conexiones de la empresa